Ruxolitinib cream for vitiligo: a real-world study
Part of Skin clinical trials.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years or older.
- You have non-segmental vitiligo (the type that affects both sides of the body).
- Your vitiligo covers less than 10% of your body's skin surface.
- You agree to stop all other vitiligo treatments during the study.
- If you can become pregnant or get someone pregnant, you must use effective birth control during the study and for 4 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
This trial tests a cream called ruxolitinib to see if it can safely and effectively restore skin color in children with vitiligo. It may help reduce white patches on the skin.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.